Research Article
miR-22-3p/PGC1β Suppresses Breast Cancer Cell Tumorigenesis via PPARγ
Table 1
The relationship between the expression of miR-22-3p and various clinicopathological variables.
| Patients characteristics | Total | miR-22-3p expression | value | High () | Low () |
| Age | | | | 0.7065 | <60 | 20 | 5 | 15 | | ≥60 | 27 | 7 | 20 | | TNM stage | | | | 0.0200 | I and II | 30 | 11 | 19 | | III and IV | 17 | 1 | 16 | | Tumor size (cm) | | | | 0.0237 | ≤2 | 26 | 10 | 16 | | >2 | 21 | 2 | 19 | | Lymph node metastasis | | | | 0.0423 | Negative | 32 | 11 | 21 | | Positive | 15 | 1 | 14 | | Distant metastasis | | | | 0.0931 | No | 40 | 12 | 28 | | Yes | 7 | 0 | 7 | |
|
|
value from a chi-square test ( ). |